Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill aims to address antibiotic-resistant bacteria through federal action and coordination.
The problem
Antibiotic-resistant bacteria, called superbugs, are spreading and causing infections that drugs cannot treat, threatening public health.
The proposal
The bill likely establishes federal programs, research funding, and coordination efforts to combat antibiotic resistance and reduce superbug infections.
The impact
Hospitals, patients, healthcare workers, and pharmaceutical companies are affected by new standards, research requirements, and potential regulations on antibiotic use.
Addressing antibiotic resistance protects millions of Americans from untreatable infections. This can reduce serious illnesses and deaths from superbugs.
Federal funding encourages development of new antibiotics and treatments. This helps create medical solutions for resistant bacteria.
Federal programs connect hospitals, labs, and agencies to track and fight superbugs more effectively across states.
Preventing superbug infections reduces expensive hospital stays and emergency treatments. This saves money for patients and healthcare systems.
New federal programs require taxpayer funding. The exact cost depends on program scope and duration.
Hospitals and pharmaceutical companies may face new requirements and compliance costs. Smaller facilities might struggle with additional rules.
Antibiotic development is expensive and profits are limited since these drugs are used sparingly. Companies may still avoid this market.
Coordinating antibiotic resistance efforts across states, hospitals, and agencies is complex. Success depends on effective execution and cooperation.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.